YCBD - cbdMD Inc. Net earnings per share (EPS TTM)

Symbol and logo of brand cbdMD Corp (YCBD)

cbdMD, Inc. (YCBD) relies on patents for pure raw materials, maintaining moderate pricing power. The TTM net income per share on the GURU.Markets chart reflects profit dynamics, where the value of -0.31 serves as the current metric. High competition within the CBD niche creates risks, while operational restructuring and the abandonment of mergers shift the company's development vector toward increasing online sales margins.

YCBD (cbdMD, Inc.) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/13/2026

YCBD (cbdMD Inc.): analytical breakdowns and indicator data

- share price and expert price forecast:
Stock Quotes cbdMD Corp|YCBD - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization cbdMD, Inc.|YCBD - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share cbdMD|YCBD - Total Stockholders' Equity|Market Value to Book Value Ratio cbdmd.com|YCBD - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital cbdMD, Inc.|YCBD - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital cbdMD Corp|YCBD - Company Debts|Debts to Book Capitalization cbdMD, Inc.|YCBD - Company Long-Term Indebtedness|Company Short-Term Debt cbdMD|Quick Ratio cbdmd.com
- net income and valuation multiples indicators:
YCBD - Company Profit|Future Profit cbdMD, Inc.|YCBD - Company Value to Net Income|Forward P/E Multiple cbdMD Corp|YCBD - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization cbdMD, Inc.|YCBD - Operating profit before amortization|Net earnings per share (EPS TTM) cbdMD|YCBD - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months cbdmd.com|YCBD - Expected net earnings per share growth this year|Expected earnings per share growth for next year cbdMD, Inc.
- revenue and sales proceeds data:
YCBD - Company Total Revenue|Projected Sales Volume cbdMD Corp|YCBD - Market Cap to Revenue|Forward P/S Multiple cbdMD, Inc.
Fundamental company valuation:cbdmd.com (YCBD)
Manufactured products of cbdMD Inc.

The net income per share dynamics for the trailing twelve months (TTM) reflect the effectiveness of cbdMD, Inc. (YCBD) in adapting its brand to an oversaturated market following restructuring. This metric synthesizes data from 10-Q and 10-K filings, eliminating temporary gaps between reports. The calculation is based on dividing the total annual profit by the number of shares outstanding. This metric measures the business's actual return on each share of capital. This asset is categorized as a speculative security with a moderate level of market confidence.

Direct competitors

HLN: Net earnings per share for the last 12 months|kenvue.com - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Limited - Earnings per share for the trailing year|LGND (Ligand Pharma) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Amneal Corp AMRX|Earnings per share for the last twelve months Perrigo Company plc (PRGO)|ALVO (alvotech.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LQDA (Liquidia)|GLPG - Net earnings per share for the last 12 months|ANI Pharma - Net earnings per share (EPS TTM)|MNKD: Earnings per share for the last twelve months|AMPH: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months PCRX|Earnings per share for the last twelve months ARS Pharmaceuticals, Inc.|Net earnings per share for the last 12 months Theravance Biopharma Inc (TBPH)|Net earnings per share (EPS TTM) AQST|scpharmaceuticals.com - Earnings per share for the last 12 months|Tectonic Therapeutic - Net earnings per share for the last 12 months|Earnings per share for the trailing year TNXP|SXT China - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Eupraxia Pharmaceuticals EPRX|BioHarvest (BHST) - Earnings per share for the last twelve months|Earnings per share for the last 12 months EXOZ|ORMP (Oramed) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Entera Bio Corp (ENTX)|Net earnings per share for the last 12 months HYFT (MindWalk Holdings Inc.)|Net earnings per share for the last four quarters ABVC BioPharma Inc.|Cumberland Pharma - Net earnings per share for the last 12 months|Quantum BioPharma Corp (QNTM) - Net earnings per one share for the last twelve months|FibroGen, Inc. - Net earnings per share (EPS TTM)|telomirpharma.com (TELO) - Net earnings per share for the last 12 months|RANI: Net earnings per share (EPS TTM)|SNYR (Synergy CHC) - Earnings per share for the last twelve months|RLYB (Rallybio Corp) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LEXX (Lexaria)|Earnings per share for the last twelve months Pulmatrix, Inc. (PULM)|PTHL: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) APM (Aptorum Group)|Earnings per share for the trailing year LYRA|Impact BioMedical Inc - Net earnings per share (EPS TTM)|TNFA - Net earnings per share (EPS TTM)|PainReform Ltd. (PRFX) - Earnings per share for the last twelve months|Altamira Therapeutics Ltd. - Earnings per share for the trailing year|Earnings per share for the last twelve months Lipella Pharmaceuticals, Inc.|Net earnings per share for the last 12 months OptiNose Inc (OPTN)|Net earnings per share (EPS TTM) PIRS|Net earnings per share (EPS TTM) Procaps Group Corp (PROC)|Petros Pharmaceuticals - Net earnings per share for the last 12 months|Earnings per share for the trailing year QLI|SLRN - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months TFF Pharmaceuticals Inc.